Magnetic resonance imaging (MRI) remains the test of choice for many conditions owing to its safety profile and excellent soft tissue contrast without associated exposure to iodinated contrast or ionizing radiation.
1 One estimate is that 50% to 75% of patients with cardiac implantable electronic devices (CIEDs) will have an indication for MRI during their lifetime.
2 While the development of MRI-conditional devices has the potential to enhance access to MRI for patients with such devices, there are a large number of patients with nonconditional or legacy devices. Recent data suggesting safety of scanning patients with these devices
3-5 has led to supportive specialty society guidelines and expert consensus documents, as well as changes in Centers for Medicare & Medicaid Services (CMS) reimbursement policies for MRI in patients with legacy CIED systems.
6-8 However, abandoned leads, which are theoretically associated with higher risk to adjacent structures including functional leads due to greater lead tip heating compared with leads attached to a generator,
9 remain a contraindication to MRI examination in many institutions and are excluded from CMS reimbursement due to a paucity of safety data.